Anti-HIV Drugs Cause Mitochondrial Dysfunction in Monocyte-Derived Macrophages-Reference-Cited by-同舟云学术

Anti-HIV Drugs Cause Mitochondrial Dysfunction in Monocyte-Derived Macrophages

Published:2022-04-19 Issue:4 Volume:66 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Wallace Jennillee¹,Gonzalez Hemil¹²,Rajan Reshma¹,Narasipura Srinivas D.¹,Virdi Amber K.¹,Olali Arnold Z.¹,Naqib Ankur³,Arbieva Zarema⁴,Maienschein-Cline Mark⁵,Al-Harthi Lena¹^ORCID

Affiliation:

1. Department of Microbial Pathogens and Immunity, Rush University Medical Center, Chicago, Illinois, USA

2. Department of Internal Medicine, Division of Infectious Diseases, Rush Medical College, Chicago, Illinois, USA

3. Rush Research Informatics Core, Rush University Medical Center, Chicago, Illinois, USA

4. Research Informatics Core, Research Resources Center, University of Illinois at Chicago, Chicago, Illinois, USA

5. Genome Research Core, University of Illinois at Chicago, Chicago, Illinois, USA

Abstract

Combination antiretroviral therapy (cART) dramatically changed the face of the HIV/AIDS pandemic, making it one of the most prominent medical breakthroughs of the past 3 decades. However, as the life span of persons living with HIV (PLWH) continues to approach that of the general population, the same cannot be said regarding their quality of life.

Funder

HHS | National Institutes of Health

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.01941-21

Reference93 articles.

1. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies

2. Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort

3. The prevalence of comorbidities among people living with HIV in Brent: a diverse London Borough